PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 53 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $31,000 | +3.3% | 8,891 | +0.3% | 0.00% | – |
| Q4 2020 | $30,000 | -6.2% | 8,867 | -2.8% | 0.00% | – |
| Q3 2020 | $32,000 | -23.8% | 9,122 | -0.3% | 0.00% | – |
| Q2 2020 | $42,000 | +55.6% | 9,150 | +12.6% | 0.00% | – |
| Q1 2020 | $27,000 | -48.1% | 8,123 | -5.5% | 0.00% | – |
| Q4 2019 | $52,000 | +44.4% | 8,592 | -0.8% | 0.00% | – |
| Q3 2019 | $36,000 | -68.7% | 8,664 | -0.7% | 0.00% | – |
| Q2 2019 | $115,000 | – | 8,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,643,704 | $27,704,000 | 2.29% |
| DAFNA Capital Management LLC | 360,542 | $1,503,000 | 0.56% |
| SABBY MANAGEMENT, LLC | 124,788 | $520,000 | 0.28% |
| Rock Springs Capital Management LP | 1,416,900 | $5,908,000 | 0.24% |
| Cormorant Asset Management, LP | 816,448 | $3,405,000 | 0.21% |
| SECTORAL ASSET MANAGEMENT INC | 196,000 | $817,000 | 0.14% |
| Leap Investments LP | 17,919 | $75,000 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 807,928 | $3,369,000 | 0.02% |
| Virtus ETF Advisers LLC | 21,738 | $91,000 | 0.02% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 20,000 | $83,000 | 0.01% |